IN2014CN02963A - - Google Patents

Info

Publication number
IN2014CN02963A
IN2014CN02963A IN2963CHN2014A IN2014CN02963A IN 2014CN02963 A IN2014CN02963 A IN 2014CN02963A IN 2963CHN2014 A IN2963CHN2014 A IN 2963CHN2014A IN 2014CN02963 A IN2014CN02963 A IN 2014CN02963A
Authority
IN
India
Prior art keywords
strains
generating
methods
host cells
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Bo Jiang
Rebecca D Argyros
Stephanie Nelson
Robert C Davidson
Ronghua Chen
Jun Zhuang
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of IN2014CN02963A publication Critical patent/IN2014CN02963A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN2963CHN2014 2011-10-28 2012-10-23 IN2014CN02963A (forum.php)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161552674P 2011-10-28 2011-10-28
PCT/US2012/061432 WO2013062940A1 (en) 2011-10-28 2012-10-23 Engineered lower eukaryotic host strains for recombinant protein expression

Publications (1)

Publication Number Publication Date
IN2014CN02963A true IN2014CN02963A (forum.php) 2015-07-03

Family

ID=48168381

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2963CHN2014 IN2014CN02963A (forum.php) 2011-10-28 2012-10-23

Country Status (9)

Country Link
US (1) US9328367B2 (forum.php)
EP (1) EP2771461B1 (forum.php)
JP (1) JP2014532406A (forum.php)
KR (1) KR20140091018A (forum.php)
CN (1) CN104024409A (forum.php)
AU (1) AU2012329091A1 (forum.php)
CA (1) CA2853341A1 (forum.php)
IN (1) IN2014CN02963A (forum.php)
WO (1) WO2013062940A1 (forum.php)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101790802B1 (ko) 2009-09-03 2017-10-27 머크 샤프 앤드 돔 코포레이션 항-gitr 항체
EP2771461B1 (en) 2011-10-28 2019-12-04 Merck Sharp & Dohme Corp. Engineered lower eukaryotic host strains for recombinant protein expression
US9416389B2 (en) * 2012-02-16 2016-08-16 Merck Sharp & Dohme Corp. Methods for reducing mannosyltransferase activity in lower eukaryotes
WO2014066134A1 (en) * 2012-10-22 2014-05-01 Merck Sharp & Dohme Corp. Crz1 mutant fungal cells
EP3889169A1 (en) * 2015-03-03 2021-10-06 Novartis AG Constitutive yeast llp promoter-based expression system
WO2017194699A1 (en) * 2016-05-13 2017-11-16 University Of Copenhagen A cell-based array platform
JP2018038286A (ja) * 2016-09-05 2018-03-15 国立大学法人神戸大学 新規宿主細胞及びそれを用いた目的タンパク質の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060148000A1 (en) * 1999-04-21 2006-07-06 Wyeth Methods for identifying modulators of N-type ion channel inactivation
EP1194756A4 (en) * 1999-04-21 2004-12-29 Wyeth Corp METHODS OF IDENTIFYING N-TYPE ION CHANNEL INACTIVATION MODULATORS
WO2001081548A1 (en) * 2000-04-24 2001-11-01 Wyeth Novel cell systems having specific interaction of peptide binding pairs
JP4969011B2 (ja) 2000-05-17 2012-07-04 田辺三菱製薬株式会社 酸性糖鎖減少蛋白質の製造方法および該製造された糖蛋白質
EP1522590B1 (en) 2000-06-28 2009-08-26 Glycofi, Inc. Methods for producing modified glycoproteins
US7795002B2 (en) 2000-06-28 2010-09-14 Glycofi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
JP4861830B2 (ja) 2003-12-24 2012-01-25 グライコフィ, インコーポレイテッド 糖タンパク質の産生において、グリカンのマンノシルリン酸化を除去する方法
US7465577B2 (en) 2004-04-29 2008-12-16 Glycofi, Inc. Methods for reducing or eliminating α-mannosidase resistant glycans for the production of glycoproteins
CN101606769A (zh) 2009-07-15 2009-12-23 陈德芳 一种宝石连接结构
AR087433A1 (es) * 2011-08-08 2014-03-26 Merck Sharp & Dohme Analogos de insulina n-glicosilados
EP2771461B1 (en) 2011-10-28 2019-12-04 Merck Sharp & Dohme Corp. Engineered lower eukaryotic host strains for recombinant protein expression

Also Published As

Publication number Publication date
KR20140091018A (ko) 2014-07-18
EP2771461A1 (en) 2014-09-03
US20140302557A1 (en) 2014-10-09
EP2771461A4 (en) 2015-06-17
US9328367B2 (en) 2016-05-03
WO2013062940A1 (en) 2013-05-02
AU2012329091A1 (en) 2014-05-01
CN104024409A (zh) 2014-09-03
CA2853341A1 (en) 2013-05-02
JP2014532406A (ja) 2014-12-08
EP2771461B1 (en) 2019-12-04

Similar Documents

Publication Publication Date Title
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
AU2018256629A1 (en) Methods and compositions for consumables
IN2014CN02100A (forum.php)
IN2014CN02963A (forum.php)
IN2014CN03887A (forum.php)
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
PH12013501849A1 (en) Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
MX349630B (es) Alfa-amilasas.
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
MX2018010572A (es) Inmunoglobulinas heterodimericas.
EP3763810A3 (en) T cell modifying compounds and uses thereof
MY173953A (en) Recombinant host cells for the production of malonate
MX346700B (es) Metodo para mejorar el rendimiento de un polipeptido.
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
MX2014004871A (es) Composiciones de escoria que comprenden latex y metodos de uso.
IN2014DN08721A (forum.php)
MX351565B (es) Colageno 7 y metodos relacionados.
IN2014CN03072A (forum.php)
SG195114A1 (en) Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
AU2016335217A8 (en) Antigen receptors and uses thereof
PH12013500500A1 (en) Fused heteroaryls and their uses
MX2013004981A (es) Composiciones y metodos para la administracion de agentes terapeuticos.
PH12014500207B1 (en) Biocontrol of nematodes
PH12013500616A1 (en) Antibody compositions and methods of use
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.